Vicriviroc Malate
Vicriviroc Malate Basic information
- Product Name:
- Vicriviroc Malate
- Synonyms:
-
- Vicriviroc Malate
- 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine malate
- CS-599
- CAS:
- 541503-81-5
- MF:
- C32H44F3N5O7
- MW:
- 667.7162696
- Product Categories:
-
- ProteaseInhibitors
- Mol File:
- 541503-81-5.mol
Vicriviroc Malate Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- >18mg/mL in DMSO
- form
- Powder
- InChIKey
- HQJIGHNTROUVLT-RIAYWLAYSA-N
Vicriviroc Malate Usage And Synthesis
Uses
Vicriviroc (SCH 417690) malate is an orally active CCR5 antagonist with the IC50 of 10 nM, and also inhibts MIP-1α and intracellular calcium release induced by the ligand RANTES (10 nM) with the IC50 values of 0.91 nM and 16 nM,,respectively. Vicriviroc malate can inhibits human immunodeficiency virus type 1 (HIV-1) infection, and can also used for study of cancer[1][2].
Definition
ChEBI: (4,6-Dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone;2-hydroxybutanedioic acid is a member of (trifluoromethyl)benzenes.
target
CCR5
References
[1] Strizki JM, et al. Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2005;49(12):4911-4919. DOI:10.1128/AAC.49.12.4911-4919.2005
[2] Bessudo A, et al. Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer. Clin Colorectal Cancer. 2024;23(3):285-294. DOI:10.1016/j.clcc.2024.05.003
Vicriviroc MalateSupplier
- Tel
- 0550-5196001 15000891977
- wj520wjxby@126.com
- Tel
- sales@boylechem.com
- Tel
- 86-21-34053660
- sale@labgogo.com
- Tel
- 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
- Tel
- +1 (866) 930-6790
- info@adooq.com